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Edited by Laszlo NagyAbstract Critical changes occurring in Rac-1 molecule, a cyto-
skeleton organizing small GTPase associated with cell ruﬄing,
have been analyzed in dendritic cells (DCs) derived from mono-
cytes cultured with granulocyte-macrophage colony-stimulating
factor and IFN-a or IL-4. Although with diﬀerent kinetics, both
agents induced activation of Rac-1 molecule and, more impor-
tantly, an upregulation of both protein expression and mRNA
transcription. These ﬁndings strengthen the role of Rac-1 mole-
cule in the induction of DC diﬀerentiation and suggest that, be-
sides its activation, the upregulation of Rac-1 molecule might
also play a role in the acquisition of DC mature phenotype.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Dendritic cells (DCs) are professional antigen presenting cells
considered as essential regulators of both innate and acquired
immune responses [1–3]. In addition to their phenotypic and
functional features, DCs show a speciﬁc morphology that dis-
tinguishes them from others of the immune system, i.e., the den-
dritic-like protrusions. Accordingly, DCs need a dynamic
organization of cytoskeleton, which can render them capable
of a ﬂexible activity leading to their phenotypic and migratory
properties [4,5]. The actin microﬁlament integrity and function
are pre-requisites for the occurrence of important events asso-
ciated to cell polarization and movements as well as to activities
such as antigen presentation or phagocytosis [6]. Actin cyto-
skeleton organization is controlled by proteins belonging
to the Rho family [7–9]. The Rho family encompasses three dif-
ferent subfamilies of small GTPases, all controlling the actinAbbreviations: DCs, dendritic cells; GM-CSF, granulocyte-macro-
phage colony-stimulating factor; IFN-a, interferon a; IL-4, interleukin
4; LPS, lipopolysaccharide; SEM, scanning electron microscopy
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doi:10.1016/j.febslet.2006.04.095cytoskeleton: (i) Rho subfamily, which induces the assembly
of F-actin stress ﬁbers, typical of adhering cells; (ii) Rac sub-
family, involved in the ruﬄing activity, typical of spreading
cells; and (iii) Cdc42 subfamily, which is of relevance in the
generation of the cell ﬁlopodia [10]. Interestingly, some lines
of evidence have previously indicated that the impairment of
this molecules results in the hindering of both extension and
contraction of dendrites in mature DCs [11,12]. Furthermore,
Rac-1 molecule activation seems to be required for short-range
migration and T cell priming [13]. In this context, the present
work deals with the molecular changes occurring to Rac-1
molecule during monocyte-derived DC diﬀerentiation induced
by granulocyte-macrophage colony-stimulating factor (GM-
CSF) and interleukin 4 (IL-4) (IL-4-DCs), an extensively used
and well known DC diﬀerentiating agent, or by GM-CSF
and interferon a (IFN-a, IFN-DCs) a cytokine recently de-
scribed as a potent DC maturating agent [14].2. Materials and methods
2.1. Cell culture and treatments
DCs were generated from peripheral blood mononuclear cells iso-
lated by Ficoll-Hypaque (Flow Laboratories, Hornby, Ont.) as stated
elsewhere (14) obtained from 14 diﬀerent healthy donors. Highly en-
riched monocytes (>95% CD14+) were cultured at 6 · 105/ml in RPMI
1640 medium supplemented with 15% heat-inactivated fetal calf serum,
L-glutamine and penicillin–streptomycin and 250 ng/ml GM-CSF
(PeproTech, London, England) and either IL-4 (250 U/ml,
IL-4-DCs) (R&D Systems, Minneapolis, MN) or natural IFN-a
(Alfaferone, AlfaWasserman) at the concentration of 10000 U/ml
(IFN-DCs). After 3 (for IFN-DCs) or 5 days (for IL-4-DCs) of culture,
200 ng/ml lipopolysaccharide (LPS) (Escherchia coli serotype 0111:B4,
Sigma, St. Louis, MO) was added to DCs for 24 h. To inactivate Rho
molecules, Clostridium diﬃcile Toxin B (CdB) (10 ng/ml, Sigma–Al-
drich), a bacterial protein toxin able to impair the interaction of
Rho molecules with their substrates [15], was used. The toxin was
administered to DCs 4 h before treatments with IL-4 or IFN-a cyto-
kines and leaved in the medium during DC diﬀerentiation.
2.2. Flow cytometry analyses
Cell staining was performed using mouse monoclonal antibodies
(mAbs) FITC or PE conjugate. Cells were incubated for 30 min at
4 C with the following mAbs: CD1a (IgG1, FITC clone HI149),
HLA-DR (IgG2a, FITC clone G46-6), CD80 (IgG1, FITC clone
L307.4) CD83 (IgG1, PE-clone HB15e) (all from BD Biosciences,
San Jose, CA). Cells were then washed with cold PBS and analyzed with
a FACScan (Becton Dickinson, Mountain View, CA, USA) equipped
with a 488 argon laser. At least 10000 events have been acquired. As
regards quantitative analyses of intracellular Rac-1 small-GTPase pro-blished by Elsevier B.V. All rights reserved.
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Laboratories, Burlingame, CA) and stained with mAbs for the detec-
tion of Rac-1 (Upstate Biotechnology), for 1 h at 37 C. After washing,
cells were incubated for 30 min at 37 C with FITC-labeled anti-mouse
mAbs (Sigma). Cells were then analyzed with a FACScan (Becton–
Dickinson). At least 20000 events have been acquired. Data were
recorded and statistically analyzed by a Macintosh computer using Cell-
Quest Software. Statistical signiﬁcance of ﬂow cytometry studies was cal-
culated by using the parametric Kolmogorov–Smirnov (K/S) test.
2.3. Scanning electron microscopy
IFN-DCs and IL-4-DCs were collected and plated on poly-L-lysine
coated slides, ﬁxed with 2.5% glutaraldehyde and post-ﬁxed in 1%
OsO4 as previously described [14]. The samples were examined with
a Cambridge 360 scanning electron microscopy.
2.4. Static cytometry analyses
To visualize intracellular distribution of Rac-1 small-GTPase pro-
tein, monocytes and DCs were collected and plated on poly-L-lysine
coated slides, ﬁxed for 30 min in 3.7% paraformaldehyde, and perme-
abilized with 0.5% triton X-100. Cells were then stained using Rac-1
mAb (Upstate, Biotechnology) for 1 h at 37 C. After washing, cells
were incubated for 30 min at 37 C with FITC-labeled anti-mouse
mAb (Sigma). For F-actin detection, cells were stained with ﬂuores-Fig. 1. Cytokine-induced phenotypic diﬀerentiation and surface ruﬄing. Tre
DC diﬀerentiation markers (CD1a, CD80, CD83 and HLA-DR). Note diﬀe
resulted in bolstering marker expression in both experimental conditions. Also
days with IL-4 and 3 days with IFN-a) due to the diﬀerent kinetics of DC mat
electron microscopy analyses (second and fourth rows) clearly show that
experimental conditions (1 day) but they were observable earlier in IFN-a tcein–phalloidin (Sigma) at 37 C for 30 min. Finally, all samples were
mounted with glycerol–PBS (2:1) and observed by intensiﬁed video
microscopy by using a Nikon Microphot ﬂuorescence microscope
equipped with a color chilled 3CCD camera (Zeiss, Germany).
2.5. Rac-1 activation assay
IFN-DCs and IL-4-DCs were collected at diﬀerent times after cyto-
kine treatment of monocytes (1, 2, 3 and 5 days) with or without the
additional incubation step with LPS (24 h). Pull down assay was per-
formed by using small GTPase evaluation Kit for Rac-1 (Cytoskele-
ton, Denver, CO) as established by the manufacturer’s protocol.
Samples were analyzed by SDS–PAGE and Western blot analysis.
Brieﬂy, after cell lysis, proteins were loaded with PAK-PBD beads,
possessing a high aﬃnity for Rho-GTPases [16]. The immunoblots
were analyzed by densitometry and normalized as a function of the
total proteins loaded in the assay as previously described [16].
2.6. RT-PCR
Total cellular RNA was extracted using the RNeasy Kit (Quiagen).
RNA was reverse transcribed into cDNA and ampliﬁed by PCR using
the Access RT-PCR System (Promega) according to the manufacturer’s
instruction. GAPDH and Rac-1 set of primers were synthetized by M-
Medical-GENENCO (Cornaredo). The following couples of primers
were used: GAPDH: sense 5 0-GTC TTC ACC ATG GAG AAGatments with IL-4 or IFN-a cytokines lead to increased expression of
rent kinetics between the two cytokines. LPS (arrows) administration
note that LPS administration was performed at diﬀerent time points (5
uration with cytokines (ﬁrst and third rows). In the same vein, scanning
cell surface protrusions and ruﬄing were early detectable in both
reated cells (fourth row).
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Rac-1 sense: 5 0-TCT TCT CCT TCA GTT TCT CGA TCG-3 0; anti-
sense 5 0-CAAGAAGATTATGACAGATTACGCCC-3 0. To avoid
contamination, in all experiments a control RT-PCRwithout RNAwas
conducted. For densitometric analysis, the reaction products were elec-
trophoresed through a 1.8% agarose gel (Bio-Rad). Ethidium bromide-
stained gels were scanned with a densitometer (Bio-RadMulti Analyst)
and Rac-1 mRNA levels were normalized to GAPDH mRNA levels.3. Results and discussion
3.1. Cytokine-induced DC diﬀerentiation
In the evaluation of the stage of diﬀerentiation/activation of
DCs, a great importance is generally given to the morpholog-
ical analyses [17]. Thus, we ﬁrst carried out a scanning electron
microscopy (SEM) analysis for comparing IL-4-DCs with
IFN-DCs at early times after cytokine treatment of monocytes.
Parallel analyses were also conducted evaluating the typical
diﬀerentiation markers of DCs. With respect to undiﬀerenti-
ated monocytes (not shown), the exposure to IL-4 (Fig. 1, sec-
ond row) or to IFN-a (Fig. 1, fourth row) resulted in a
remodeling of the cell with the occurrence of a series of cell sur-
face modiﬁcations, e.g., surface ruﬄing, that are typical of cell
spreading and can be easily detected by SEM observations.
However, signiﬁcant diﬀerences were detectable between cells
exposed to IL-4 and those exposed to IFN-a treatment. In par-
ticular, a pronounced cell ruﬄing and spreading was rapidlyFig. 2. Cell cytoskeleton remodeling. With respect to monocytes (left), treatm
actin network and Rac-1 molecule. This was well evident in the ruﬄes and p
LPS administration bolstered these changes (LPS+, right panel, note the incre
(panel B) hindered Rac-1 (upper micrograph) and actin (lower micrograph) c
SEM (middle). Representative results obtained 2 days after IFN-DCs incubinduced by IFN-a (after 2 days) whilst these changes were de-
tected after 5 days with IL-4 (compare SEM pictures in Fig. 1).
In the same vein, parallel analyses aimed at evaluating surface
expression of typical DC diﬀerentiation/activation markers
(CD1a, HLA-DR, CD80, CD83), also indicated a more rapid
response of IFN-DCs with respect to IL-4-DCs (Fig. 1, ﬁrst
and third rows, results obtained from a representative healthy
donor). Interestingly, IFN-a induced the expression of CD83,
a maturation antigen, after 1 day of treatment. As expected,
LPS treatment further increased cell surface ruﬄing and in-
duced an upregulation of surface marker expression typical
of mature DCs (Fig. 1, arrows indicate LPS administration).
3.2. Cytoskeleton rearrangement during DC diﬀerentiation
Literature data suggest that morphological changes detected
on the surface of DCs (i.e., surface ruﬄes) are speciﬁcally asso-
ciated with the activation of a small GTPase of the Rho family:
the Rac-1 molecule [18]. Hence, we analyzed the actin network
and Rac-1 arrangement in both IL4-DCs and IFN-DCs. With
respect to monocytes, we found: (i) a redistribution of Rac-1
molecule in both experimental conditions (Fig. 2, panel A,
upper rows) and (ii) a rearrangement of actin ﬁlaments
(Fig. 2, panel A, bottom rows). However, according to litera-
ture [14] these changes were detected at shorter time points in
IFN-DCs (3 days) with respect to IL-4-DCs (5 days). Further-
more, after LPS treatment these changes were even moreents with IL-4 and IFN-a (panel A) induced a rearrangement of both
rotrusions visible in the apical regions of cells (middle panel), Further
ased cell polarity). Treament with CdB before cytokine administration
ytoskeleton remodeling. Accordingly, no surface ruﬄes were visible by
ation with CdB are shown. Magniﬁcation 3000·.
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actually parallel SEM observations depicted above (see Fig. 1)
and show for the ﬁrst time a speciﬁc rearrangement and redis-
tribution of Rac-1 molecule during DC diﬀerentiation. Inter-
estingly, treatment with a bacterial protein toxin able to
impair Rho-GTPase function, the C. diﬃcile toxin B (CdB),
before cytokine administration, clearly hindered DC actin
cytoskeleton remodeling. CdB treated cells failed to show
any sign of cell ruﬄing after both IL-4 (not shown) or IFN-
a treatments, as detected by SEM analysis (Fig. 2, panel B,
middle micrograph). In fact, the cytokine-induced Rac-1 and
microﬁlament redistribution was impaired by CdB (Fig. 2,
panel B, upper and bottom micrographs, respectively).
3.3. Rac-1 activation and upregulation during DC diﬀerentiation
Since small GTPases [11,19,20] are able to cycle between two
conformational states, an ‘‘active’’ state, bound to GTP (Rac-1
GTP) and an ‘‘inactive’’ state, bound to GDP (Rac-1 GDP),
the activation of Rac-1 molecule was ﬁrst evaluated by pull-
down experiments at diﬀerent culture times. After short timeFig. 3. Rac-1 analyses. Rac-1 activation. Cytokine treatments lead to Rac-1 a
Rac-1 molecule after 1 day. LPS administration resulted in further Rac-1 a
expression. Flow cytometric analyses indicated an increased Rac-1 expression
further upregulated Rac-1. The histograms show mean values obtained from
separate experiments. Rac-1 mRNA. Evaluation of Rac-1 mRNA level clea
treatments (D,E). Note that Rac-1 mRNA was further increased by LPS tretreatments (4 h), no signiﬁcant diﬀerence was detected in the
activation of Rac-1 molecule between IFN-DCs and IL-4-
DCs as compared to undiﬀerentiated monocytes. By contrast,
longer exposure times (1–3 days) clearly showed Rac-1 activa-
tion state in the DC cultures (Fig. 3, panel A). Notably, at ear-
lier time points (1 day), the activation of Rac-1 molecule was
less evident in IL-4-DCs with respect to IFN-DCs (Fig. 3, pa-
nel A). After LPS treatment, the activation of Rac-1 was well
evident in both experimental conditions (Fig. 3, panel A, re-
sults obtained after 3 days for IFN-DCs and after 5 days for
IL-4-DCs are shown). The diﬀerences in terms of diﬀerentia-
tion pattern between IL-4-DCs and IFN-DCs were previously
investigated elsewhere [14]. However, we show here that Rac-1
GTPase activation, previously hypothesized to be of impor-
tance in DC migration and homing [13], seems to reﬂect the
diﬀerentiation pathways induced by the two cytokines, faster
in IFN-DCs.
Furthermore, quantitative analyses of the expression of to-
tal Rac-1 molecule were also conducted. An increased expres-
sion of this molecule was detected by Western blot (Fig. 3A)ctivation. Notably, IFN-a treatment leads to a signiﬁcant GTP-bound
ctivation (A). Note low Rac-1 activation in monocytes (day 0). Rac-1
after IL-4 (B) as well as after IFN-a (C) treatments. LPS administration
median values of ﬂuorescence intensity histograms obtained from eight
rly indicated the upregulation of the molecule in response to cytokine
atment in IL-4-DCs only (D).
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IFN-DCs). These results (mean values ±SD obtained from
DCs from 14 healthy donors) clearly indicated that a time
dependent upregulation of Rac-1 molecule in cytokine treated
cells with respect to untreated monocytes (day 0). A further
increase of Rac-1 molecule was also detected in IL-4-DCs
and IFN-DCs after LPS treatment, reaching a peak level
after 5 and 3 days treatments, respectively (Fig. 3B and C,
grey histograms). Hence, in view of this protein upregulation,
we decided to evaluate Rac-1 mRNA level in our DC diﬀer-
entiation model. Notably, a gradual upregulation of Rac-1
mRNA level was detected in IL-4-DCs (Fig. 3D) as well as
in IFN-DCs (Fig. 3E). Of notice, a further increase of Rac-
1 mRNA was also detected after LPS administration, but
in IL-4-DCs only. (Fig. 3D).4. Conclusions
Administration of cytokines was known to bolster diﬀerenti-
ation of DCs in terms of phenotype, morphology, migration
capability and immune priming activities [14,18]. We have
shown here that Rac-1 molecule, a small GTPase involved in
actin cytoskeleton network remodeling, although with diﬀerent
kinetics, was potently activated by both IL-4 and IFN-a
administration as well as by the subsequent treatments with
LPS. Intriguingly, we also found that an upregulation of
Rac-1 protein, in terms of both protein expression and mRNA
level, can be detected in diﬀerentiating DCs. Rac-1 GTPase, in
its activated form, i.e., the GTP bound form, has been associ-
ated with a series of subcellular changes leading to increased
cell polarity and to an increased spreading pattern [10]. In fact,
Rac-1 small GTPase belongs to the family of Rho proteins,
i.e., Rho Rac and Cdc42, that, once activated, instruct actin
network remodeling associated with cell adhesion dynamics,
cell ruﬄing and the formation of cell protrusions [7–10]. Alto-
gether these ﬁndings, allow to identify Rac-1 upregulation and
activation, as important steps in IFN and IL4-induced diﬀer-
entiation of monocytes into DCs allow in terms of migration
ability and immunological synapse formation in response to
danger signals [6].
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